Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | KDM1A | O60341 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 2/20 | 0.37 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21294818 | 0.90 | BTK (0.48) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL28332560 | 0.90 | BTK (0.48) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL1555126 | 0.88 | BTK (0.48) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL16095512 | 0.86 | BTK (0.42) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL4359773 | 0.85 | BTK (0.42) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL4359769 | 0.85 | BTK (0.42) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL4364904 | 0.85 | BTK (0.42) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL4364906 | 0.85 | BTK (0.42) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL22199265 | 0.84 | BTK (0.41) | BTKGAAKDM1AMAOBEPHX2 | |
| SCHEMBL1457503 | 0.84 | BTK (0.41) | BTKGAAKDM1AMAOBEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747250-A1 | KINASE INHIBITORS | The United States Of America, As Represented By The Secretary, Department of Health and Human Services (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2025019585-A1 | KINASE INHIBITORS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-01-23 | — | — | WO | disclosed |